Cargando…

Continuous Wave Fractional CO(2) Laser for the Treatment of Upper Eyelid Dermatochalasis and Periorbital Rejuvenation

Fractional continuous wave CO(2) laser resurfacing is used to improve photodamage, wrinkles, and acne scarring by surface ablation and by using heat to activate natural collagen production and dermal remodeling. In this study, the author examined the efficacy and safety of nonincisional continuous w...

Descripción completa

Detalles Bibliográficos
Autor principal: Toyos, Melissa Morrison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439434/
https://www.ncbi.nlm.nih.gov/pubmed/28085575
http://dx.doi.org/10.1089/pho.2016.4225
_version_ 1783237947543257088
author Toyos, Melissa Morrison
author_facet Toyos, Melissa Morrison
author_sort Toyos, Melissa Morrison
collection PubMed
description Fractional continuous wave CO(2) laser resurfacing is used to improve photodamage, wrinkles, and acne scarring by surface ablation and by using heat to activate natural collagen production and dermal remodeling. In this study, the author examined the efficacy and safety of nonincisional continuous wave fractional CO(2) laser blepharoplasty in the upper lid. Standard lid measurements including marginal reflex distance, palpebral fissure, and upper lid crease were performed preoperatively and at 6 months by the surgeon. All patients underwent full facial MIXTO continuous wave CO(2) laser treatment (MIXTO Slim Evolution 2; MIXTOLasering USA, San Ramon, CA), including resurfacing on the upper eyelid from lashes to brow. We evaluated results at 6 months after laser treatment and found that on average, after MIXTO continuous wave laser treatment, marginal reflex distance of the upper lid increased from baseline from 0.7 to 2.2 mm, palpebral fissures increased from 5.6 to 7.4 mm, the upper lid crease was unchanged at 5.7 mm as was the upper lid excursion at 14.7 mm compared with those before treatment. Patients reported postoperative erythema, edema, crusting, and oozing that resolved within 14 days. These data demonstrate the safety and efficacy of noninvasive continuous wave fractional CO(2) laser in the treatment of mild and moderate upper eyelid dermatochalasis.
format Online
Article
Text
id pubmed-5439434
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Mary Ann Liebert, Inc.
record_format MEDLINE/PubMed
spelling pubmed-54394342017-05-30 Continuous Wave Fractional CO(2) Laser for the Treatment of Upper Eyelid Dermatochalasis and Periorbital Rejuvenation Toyos, Melissa Morrison Photomed Laser Surg Original Research Fractional continuous wave CO(2) laser resurfacing is used to improve photodamage, wrinkles, and acne scarring by surface ablation and by using heat to activate natural collagen production and dermal remodeling. In this study, the author examined the efficacy and safety of nonincisional continuous wave fractional CO(2) laser blepharoplasty in the upper lid. Standard lid measurements including marginal reflex distance, palpebral fissure, and upper lid crease were performed preoperatively and at 6 months by the surgeon. All patients underwent full facial MIXTO continuous wave CO(2) laser treatment (MIXTO Slim Evolution 2; MIXTOLasering USA, San Ramon, CA), including resurfacing on the upper eyelid from lashes to brow. We evaluated results at 6 months after laser treatment and found that on average, after MIXTO continuous wave laser treatment, marginal reflex distance of the upper lid increased from baseline from 0.7 to 2.2 mm, palpebral fissures increased from 5.6 to 7.4 mm, the upper lid crease was unchanged at 5.7 mm as was the upper lid excursion at 14.7 mm compared with those before treatment. Patients reported postoperative erythema, edema, crusting, and oozing that resolved within 14 days. These data demonstrate the safety and efficacy of noninvasive continuous wave fractional CO(2) laser in the treatment of mild and moderate upper eyelid dermatochalasis. Mary Ann Liebert, Inc. 2017-05-01 2017-05-01 /pmc/articles/PMC5439434/ /pubmed/28085575 http://dx.doi.org/10.1089/pho.2016.4225 Text en © Melissa Morrison Toyos, 2016; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Original Research
Toyos, Melissa Morrison
Continuous Wave Fractional CO(2) Laser for the Treatment of Upper Eyelid Dermatochalasis and Periorbital Rejuvenation
title Continuous Wave Fractional CO(2) Laser for the Treatment of Upper Eyelid Dermatochalasis and Periorbital Rejuvenation
title_full Continuous Wave Fractional CO(2) Laser for the Treatment of Upper Eyelid Dermatochalasis and Periorbital Rejuvenation
title_fullStr Continuous Wave Fractional CO(2) Laser for the Treatment of Upper Eyelid Dermatochalasis and Periorbital Rejuvenation
title_full_unstemmed Continuous Wave Fractional CO(2) Laser for the Treatment of Upper Eyelid Dermatochalasis and Periorbital Rejuvenation
title_short Continuous Wave Fractional CO(2) Laser for the Treatment of Upper Eyelid Dermatochalasis and Periorbital Rejuvenation
title_sort continuous wave fractional co(2) laser for the treatment of upper eyelid dermatochalasis and periorbital rejuvenation
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439434/
https://www.ncbi.nlm.nih.gov/pubmed/28085575
http://dx.doi.org/10.1089/pho.2016.4225
work_keys_str_mv AT toyosmelissamorrison continuouswavefractionalco2laserforthetreatmentofuppereyeliddermatochalasisandperiorbitalrejuvenation